Who is at risk of low blood sugar on Zepbound, and what are the warning signs?

Patients using Zepbound with insulin or sulfonylureas are at the highest risk for low blood sugar (hypoglycemia), with warning signs like shakiness and dizziness.

Primary Risk Factors for Hypoglycemia on Zepbound

The risk of low blood sugar (hypoglycemia) while taking Zepbound is low for most patients. However, the risk significantly increases when Zepbound is used concurrently with medications that stimulate insulin secretion, such as sulfonylureas (e.g., glipizide, glyburide), or with external insulin.

Zepbound works in part by stimulating the pancreas to release insulin in response to high blood glucose. This mechanism has a natural brake. In contrast, sulfonylureas and injected insulin lower blood sugar regardless of glucose levels. The combination can lead to an excessive insulin effect and a drop in blood sugar.

Clinical trials support this finding. In the SURMOUNT-2 study of adults with type 2 diabetes, clinically significant hypoglycemia (blood glucose <54 mg/dL) was reported in 1.1% of patients on Zepbound 15 mg alone, but in 14.8% of patients taking Zepbound 15 mg with a background sulfonylurea. This highlights the importance of medication review with your physician.

Your physician may recommend reducing the dose of your sulfonylurea or insulin when you begin or increase your dose of Zepbound. This proactive adjustment is a key safety measure to mitigate the risk of hypoglycemia. Never adjust medication doses on your own; always follow the guidance of your prescribing physician.

Warning Signs and Symptoms of Low Blood Sugar

Recognizing the early signs of hypoglycemia is crucial for prompt treatment. Common early symptoms include dizziness, shakiness, lightheadedness, anxiety, irritability, and a fast heartbeat or palpitations. You might also experience sweating, chills, headache, or sudden, intense hunger.

As blood sugar continues to fall, neuroglycopenic symptoms may appear due to the brain being deprived of glucose. These can include blurred or double vision, confusion, difficulty concentrating, slurred speech, drowsiness, and unusual behavior. It is important to treat hypoglycemia before it progresses to this stage.

Symptoms can differ from person to person and even from one episode to the next. It's vital to learn your own personal warning signs. Some individuals, particularly those with long-standing diabetes, may develop "hypoglycemia unawareness," where they no longer experience the early warning signs, increasing the risk of severe events.

What Constitutes Clinically Significant Hypoglycemia?

Hypoglycemia is defined by a specific blood glucose measurement, not just by symptoms. According to the American Diabetes Association (ADA), a blood glucose level below 70 mg/dL (3.9 mmol/L) is considered a hypoglycemia alert value (Level 1) that warrants action.

Clinically significant hypoglycemia (Level 2) is defined as a blood glucose level below 54 mg/dL (3.0 mmol/L). At this level, the body's supply of glucose is insufficient for normal brain function, and neuroglycopenic symptoms are likely to occur. This is a serious condition requiring immediate treatment.

Severe hypoglycemia (Level 3) is the most dangerous form and is defined by severe cognitive impairment that requires assistance from another person for recovery. The person may be unable to swallow or may experience seizures or loss of consciousness. This is a medical emergency.

How to Manage and Prevent Low Blood Sugar

If you experience symptoms of low blood sugar, check your glucose level if a meter is available. If it's below 70 mg/dL or you can't check, follow the "Rule of 15." Consume 15 grams of a fast-acting carbohydrate, such as 4 glucose tablets, 4 ounces of fruit juice or regular soda (not diet), or 1 tablespoon of sugar or honey.

After consuming the carbohydrates, wait 15 minutes and then recheck your blood sugar. If it is still below 70 mg/dL, repeat the process. Once your blood sugar returns to normal, eat a small snack containing protein and carbohydrates (like crackers with cheese) if your next meal is more than an hour away.

Prevention is key, especially for those at high risk. Your physician will carefully review your medication list and may adjust doses of insulin or sulfonylureas. Regular blood glucose monitoring is also essential, particularly when starting Zepbound, changing your dose, or altering your diet or exercise routine.

Always be prepared by carrying a source of fast-acting carbohydrates with you. Consistent meal timing and discussing any changes in physical activity with your physician-supervised care team can also help maintain stable blood sugar levels. You can learn more about living with GLP-1 therapy in our full library of physician-reviewed [answers](/answers).

Bottom Line

The risk of low blood sugar on Zepbound is highest for patients also taking insulin or sulfonylurea drugs. This risk is manageable through careful, physician-supervised dose adjustments of these other medications.

Learn to recognize the warning signs of hypoglycemia, which include shakiness, sweating, dizziness, and confusion. Prompt treatment by consuming fast-acting carbohydrates is essential to prevent a severe event.

Maintain open communication with your healthcare provider about all medications you are taking and report any symptoms of low blood sugar immediately. Regular blood glucose monitoring can provide valuable information for you and your care team.

This article is for informational purposes only and does not constitute medical advice. Always consult with your physician for diagnosis and treatment.

Generated from GOAL.MD's physician-reviewed source library. This page has not received its own physician review. Physician-supervised telehealth. More at goal.md/answers.